PLAT and Stroke: Patients were age-matched across both groups, with no significant differences in the baseline stroke characteristics, tissue plasminogen activator (tPA) administration, the Alberta Stroke Program Early CT (ASPECTS) score, or collateral grade between the two groups, as assessed at the initial presentation (Table 1) [22].